Autori: Sansone VA

Filtra

Data

Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With Nusinersen

Patients on treatment with risdiplam in Italy: challenges in the interpretation of the real-world data

Association between Reported Sleep Disorders and Behavioral Issues in Children with Myotonic Dystrophy Type 1-Results from a Retrospective Analysis in Italy

Parental diagnostic delay and developmental outcomes in congenital and childhood-onset myotonic dystrophy type 1

Natural history of Becker muscular dystrophy: DMD gene mutations predict clinical severity

Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3

Therapeutic Role of Nusinersen on Respiratory Progression in Pediatric Patients With Spinal Muscular Atrophy Type 2 and Nonambulant Type 3

Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA.

Upper limb function changes over 12 months in untreated SMA II and III individuals: an item-level analysis using the Revised Upper Limb Module

Prevalence of Duchenne muscular dystrophy in Italy: a nationwide survey

Torna in alto